| Line 72: | Line 72: | ||
==Scientific Publications - Not Youth Specific== | ==Scientific Publications - Not Youth Specific== | ||
<br> | <br> | ||
===2023: [https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-023-02890-y Associations between smoking and vaping prevalence, product use characteristics, and mental health diagnoses in Great Britain: a population survey]=== | |||
*Smoking, vaping and dual use were substantially higher among those with a history of MHC, especially multiple MHC, and experiencing past month distress than those not having a history of MHC or experiencing past month distress respectively. Analysis used descriptive epidemiology and causation cannot be determined. | |||
*Citation: Taylor, E., Brose, L.S., McNeill, A. et al. Associations between smoking and vaping prevalence, product use characteristics, and mental health diagnoses in Great Britain: a population survey. BMC Med 21, 211 (2023). https://doi.org/10.1186/s12916-023-02890-y | |||
===2022: [https://onlinelibrary.wiley.com/doi/full/10.1111/add.15950 The relationship between smokeless tobacco (snus) and anxiety and depression among adults and elderly people. A comparison to smoking in the Tromsø Study]=== | ===2022: [https://onlinelibrary.wiley.com/doi/full/10.1111/add.15950 The relationship between smokeless tobacco (snus) and anxiety and depression among adults and elderly people. A comparison to smoking in the Tromsø Study]=== | ||
*In Norway, current snus users differ from current smokers by having a higher socio-economic status and no detectable association with anxiety and depression. This suggests that the relationship between tobacco use and anxiety and depression is associated with the administration method. | *In Norway, current snus users differ from current smokers by having a higher socio-economic status and no detectable association with anxiety and depression. This suggests that the relationship between tobacco use and anxiety and depression is associated with the administration method. | ||
edits